HIV News and Research

RSS

Crucell and AIDS Vaccine Initiative have signed an exclusive license agreement to develop an AIDS vaccine

Dutch biotechnology company Crucell and the International AIDS Vaccine Initiative (IAVI) have signed an exclusive license agreement to develop an AIDS vaccine based on Crucell’s AdVac® technology.

20 Sep 2004

Urgent measures need to be taken to protect the public from contaminated blood transfusions

In the Western Pacific Region, transmission of HIV/AIDS and other infections such as hepatitis B and C through blood transfusion remains a serious threat. It is particularly acute in areas where prevalence of these diseases is high and access to safe blood is limited.

16 Sep 2004

WHO urges Member States to act now to avoid a major HIV/AIDS epidemic

Dr Shigeru Omi, World Health Organization Regional Director for the Western Pacific, has warned of the danger of HIV "bridging" into the general population from infected individuals with high-risk behaviour unless countries and areas in the Region act now to avoid a major HIV/AIDS epidemic.

16 Sep 2004

Public health issues, AIDS, sex education and federal tobacco regulation take center stage

Republican and Democratic presidential campaign representatives today said their candidates will address the public health work force shortage, but they debated the need for sex education and federal regulation of tobacco

16 Sep 2004

Protein that causes juvenile Batten disease also plays a key role in normal cell function

The aberrant protein that causes juvenile Batten disease, a fatal neurodegenerative disorder of childhood, also plays a key role in normal cell function, Duke University Medical Center researchers have found.

16 Sep 2004

Experts discuss antibiotic resistance, tuberculosis, malaria, vaccines, maternal mortality, childhood diseases and health sector reform

New challenges ahead and the unfinished agenda in public health in the Americas" will be the focus of joint efforts by the Pan American Health Organization (PAHO) and the U.S. Agency for International Development (USAID)

14 Sep 2004

Early use of combination-drug treatments could improve HIV survival rates

Survival rates of HIV-positive patients could be improved if combination-drug treatment were begun earlier than current clinical guidelines now recommend, according to a new study by researchers from The New York Academy of Medicine and the Johns Hopkins University Bloomberg School of Public Health.

14 Sep 2004

California Chamber of Commerce lends support to stem cell research

The California Chamber of Commerce has joined with a broad and growing coalition of business groups, patient advocates and medical organizations in endorsing a "YES" vote on Proposition 71, the California Stem Cell Research and Cures Initiative, on the November 2004 statewide ballot.

14 Sep 2004

New insights into the international burden of malaria

Malaria research scientists from around the globe have published new insights into the international burden of malaria and what can be done about it.

14 Sep 2004

First molecular-scale images of DNA binding to an adenovirus enzyme

The images, which appear on the cover of the October 2004 issue of Molecular and Cellular Proteomics, show how binding to DNA may stimulate the enzyme and are already being used to design new antiviral drugs to block this interaction.

14 Sep 2004

Chiron announces settlement with Roche in HIV patent dispute

Chiron Corporation has announced that it has reached a settlement with F. Hoffmann-La Roche (Roche) in a dispute over licensing fees and royalties that Chiron had asserted was owed to the company under a licensing agreement related to its U.S. Patent No. 6,531,276 (the "276 Patent").

12 Sep 2004

World Health Organisation's strategy to control the worldwide rise of tuberculosis has not worked

The World Health Organisation's (WHO) strategy to control the worldwide rise of tuberculosis (TB) has not worked, say Harvard researchers in the Journal of Epidemiology and Community Health. It is time to go beyond simply treating people with active disease, which has been the cornerstone of its strategy, they say.

12 Sep 2004

Homophobic lyrics in reggae music, a health issue for black gay men

The issue of homophobic lyrics by certain reggae artists is being hotly debated in the media in the run-up to the MOBO awards in late September.

10 Sep 2004

New view of chromatin and gene activity

A genome - the DNA instructions for an organism - does not act alone. DNA is packaged with proteins into 'chromatin', which may be more or less tightly condensed. A popular proposal is that active genes are in 'open' chromatin (to allow access to them) and inactive genes are in tightly packed 'compact' chromatin.

10 Sep 2004

Secrecy and silence clouds the true picture of AIDS related deaths among doctors in South Africa

A culture of 'secrecy and silence' clouds the true picture of AIDS related deaths among doctors in South Africa, says Dr Dan Ncayiyana, editor of the South African Medical Journal, in this week's BMJ.

9 Sep 2004

Researchers uncover how HIV causes abnormalities in antibody-producing cells

HIV wreaks much of its damage by targeting the “orchestra conductor” of the immune system, a key class of T cells—CD4+ T cells—whose destructive relationship with HIV has been well-studied by AIDS researchers.

8 Sep 2004

Advances in gene silencing on the agenda

Recent advances in using 'RNA interference' (RNAi) to improve plant, animal and human health will be the major focus of the CSIRO-hosted Horizons in Livestock Sciences Conference on the Gold Coast from 12-15 September.

8 Sep 2004

Generic tritherapy can be used as a basic treatment for AIDS

A clinical trial, conducted in Cameroon by IRD researchers working with other organizations and supported by the ANRS, has demonstrated that one of the most common combinations currently deployed in Africa, using nevirapine, stavudine and lamivudine, satisfies these criteria.

5 Sep 2004

Many low-income countries are unlikely to reach the health targets set for 2015

Many low-income countries are unlikely to reach the Millennium Development Goal (MDG) health targets set for 2015; the main reasons for this are fragile health systems and insufficient investments in understanding how to strengthen them, suggest authors of a Public Health article in this week’s issue of THE LANCET.

2 Sep 2004

World needs to commit more resources to treat people infected with HIV

Leaders of the International AIDS Vaccine Initiative (IAVI) have stressed that as the world commits more resources to treat people infected with HIV, it must also intensify efforts to develop a vaccine to prevent new infections and stop the continuing spread of the virus.

2 Sep 2004

HIV News and Research

Crucell and AIDS Vaccine Initiative have signed an exclusive license agreement to develop an AIDS vaccine

Urgent measures need to be taken to protect the public from contaminated blood transfusions

WHO urges Member States to act now to avoid a major HIV/AIDS epidemic

Public health issues, AIDS, sex education and federal tobacco regulation take center stage

Protein that causes juvenile Batten disease also plays a key role in normal cell function

Experts discuss antibiotic resistance, tuberculosis, malaria, vaccines, maternal mortality, childhood diseases and health sector reform

Early use of combination-drug treatments could improve HIV survival rates

California Chamber of Commerce lends support to stem cell research

New insights into the international burden of malaria

First molecular-scale images of DNA binding to an adenovirus enzyme

Chiron announces settlement with Roche in HIV patent dispute

World Health Organisation's strategy to control the worldwide rise of tuberculosis has not worked

Homophobic lyrics in reggae music, a health issue for black gay men

New view of chromatin and gene activity

Secrecy and silence clouds the true picture of AIDS related deaths among doctors in South Africa

Researchers uncover how HIV causes abnormalities in antibody-producing cells

Advances in gene silencing on the agenda

Generic tritherapy can be used as a basic treatment for AIDS

Many low-income countries are unlikely to reach the health targets set for 2015

World needs to commit more resources to treat people infected with HIV

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News